mRNA |
CMK |
GDSC1000 |
pan-cancer |
AAC |
0.066 |
0.2 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.2 |
mRNA |
KIN001-270 |
GDSC1000 |
pan-cancer |
AAC |
0.041 |
0.2 |
mRNA |
FQI-2 |
CTRPv2 |
pan-cancer |
AAC |
0.038 |
0.2 |
mRNA |
Crizotinib |
gCSI |
pan-cancer |
AAC |
0.066 |
0.2 |
mRNA |
CP466722 |
GDSC1000 |
pan-cancer |
AAC |
0.036 |
0.2 |
mRNA |
R428 |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.2 |
mRNA |
FSC231 |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.2 |
mRNA |
FTI-277 |
GDSC1000 |
pan-cancer |
AAC |
-0.041 |
0.2 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.038 |
0.2 |